Geographic Infomation

6 Months Ended

Jun. 30, 2012

GEOGRAPHIC INFORMATION:

The Company and its subsidiaries are engaged in one line of business, the development, licensing, manufacturing and sale of pharmaceutical products. The Company conducts its international business through its Bermuda subsidiary which contracts with various manufacturers located in the United Kingdom, Switzerland and Italy, to make product for both its international and domestic operations. The Company’s international customers, Merck Serono and The Urology Company, sell its products into several countries.

As of July 2, 2010, with the completion of the Watson Transactions, Watson is responsible for the commercialization and sale of Progesterone Products domestically. The Company supplies Watson with finished products on a cost-plus-10% basis.

The following table shows selected information by geographic area:



	Net Revenues		Identifiable Assets
As of and for the six months ended June 30, 2012
United States	$	3,844,861	$	25,476,058
Switzerland	8,219,216		5,323,638
Other countries	—		4,316,364
Total	$	12,064,077	$	35,116,060
As of and for the six months ended June 30, 2011
United States	$	24,705,931	$	29,753,248
Switzerland	7,032,527		4,967,415
Other countries	—		926,572
Total	$	31,738,458	$	35,647,235